Your session is about to expire
← Back to Search
Vertical Positioning for Respiratory Failure
N/A
Waitlist Available
Led By John P Kress, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients aged ≥18 years who are mechanically ventilated
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 1hr
Awards & highlights
Study Summary
This trial will help researchers learn if changing from lying down to sitting up affects how well oxygen moves from the lungs into the blood for people with hypoxemic respiratory failure.
Who is the study for?
This trial is for adults over 18 who are on mechanical ventilation due to respiratory failure, with specific oxygen levels in their blood. It's not for those with severe heart rates, low blood pressure, gastrointestinal bleeding, high intracranial pressure, pregnancy, or if they weren't walking before hospitalization.Check my eligibility
What is being tested?
The study examines the impact of moving from lying down to standing up on breathing and oxygen levels in patients with hypoxemic respiratory failure. Researchers want to see if this change improves how well lungs transfer oxygen into the blood.See study design
What are the potential side effects?
Since the intervention involves changing position from supine to upright, potential side effects may include discomfort or dizziness due to movement but will largely depend on each patient's condition.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 or older and am on a mechanical ventilator.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to 1hr
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 1hr
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
PaO2 to FiO2 ratio
Secondary outcome measures
Change in blood pH
Oxygen Saturation
change in blood PCO2
Other outcome measures
Tidal Volume
Vital Signs
Trial Design
1Treatment groups
Experimental Treatment
Group I: Mechanically VentilatedExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
University of ChicagoLead Sponsor
1,004 Previous Clinical Trials
819,761 Total Patients Enrolled
5 Trials studying Respiratory Failure
30,732 Patients Enrolled for Respiratory Failure
John P Kress, MDPrincipal InvestigatorUniversity of Chicago
8 Previous Clinical Trials
2,134 Total Patients Enrolled
1 Trials studying Respiratory Failure
200 Patients Enrolled for Respiratory Failure
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your breathing rate is too slow (less than 5 breaths per minute) or too fast (more than 40 breaths per minute).You have signs of increased pressure inside your head.I have active heart-related chest pain.I was unable to walk before being hospitalized.It is unsafe for me to stand up due to my physical or mental condition.My doctor has ordered me to stay in bed at all times.I am 18 or older and am on a mechanical ventilator.People with oxygen levels between 88% and 94% or who have an arterial line.Your heart beats too slowly (less than 40 beats per minute) or too fast (more than 130 beats per minute).You need help breathing with a medical device.Your average blood pressure is less than 65.You have been very agitated and needed more sedatives in the last 30 minutes.Your pulse oximeter shows oxygen levels below 88%.I am currently undergoing a medical procedure.I am currently experiencing bleeding in my digestive tract.
Research Study Groups:
This trial has the following groups:- Group 1: Mechanically Ventilated
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger